Genomics BioSci & Tech (TPE:4195) has appointed chief executive officer Shang-Hui Wu as the acting chief operating officer of the company, effective Wednesday, following a personnel adjustment, according to a same-day filing to the Taiwan Stock Exchange.
Wu will temporarily succeed Chang Tso‑wei, who previously served as COO and chief financial officer and has undergone a position adjustment.